Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

Enhancement of bacteriolysis of Shuffled phage PhiX174 gene E

Authors: Shen-ye Yu, Wei Peng, Wei Si, Lu Yin, Si-guo Liu, Hui-fang Liu, Hai-ling Zhao, Chun-lai Wang, Yue-hong Chang, Yue-zhi Lin

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Bacterial ghosts that are generated using the regulated PhiX174 lysis gene E offer a new avenue for the study of inactivated vaccines. Here, we constructed a library of mutant gene E using a gene-shuffling technique. After screening and recombination with the prokaryotic non-fusion expression vector pBV220, two lysis plasmids were selected. Among which, a novel mutant E gene (named mE), consisting of a 74-bp non-encoding sequence at 5'-end and a 201-bp gene ΔE, significantly increased the lysis effect on prokaryotic Escherichia coli and Salmonella enteritidis. Moreover, lysis efficiency, as measured by the OD600 value, reached 1.0 (109 CFU), avoiding the bottleneck problem observed with other bacterial lysis procedures, which results in a low concentration of bacteria in suspension, and consequent low production of bacterial ghosts. Our results may provide a promising avenue for the development of bacterial ghost vaccines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bernhardt TG, Roof WD, Young R: Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. Proc Natl Acad Sci USA 2000,97(8):4297-4302. 10.1073/pnas.97.8.4297PubMedCentralCrossRefPubMed Bernhardt TG, Roof WD, Young R: Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. Proc Natl Acad Sci USA 2000,97(8):4297-4302. 10.1073/pnas.97.8.4297PubMedCentralCrossRefPubMed
2.
go back to reference Witte A, Blasi U, Halfmann G, Szostak M, Wanner G, Lubitz W: Phi X174 protein E-mediated lysis of Escherichia coli . Biochimie 1990,72(2-3):191-200. 10.1016/0300-9084(90)90145-7CrossRefPubMed Witte A, Blasi U, Halfmann G, Szostak M, Wanner G, Lubitz W: Phi X174 protein E-mediated lysis of Escherichia coli . Biochimie 1990,72(2-3):191-200. 10.1016/0300-9084(90)90145-7CrossRefPubMed
3.
go back to reference Jalava K, Hensel A, Szostak M, Resch S, Lubitz W: Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 2002,85(1-3):17-25. 10.1016/S0168-3659(02)00267-5CrossRefPubMed Jalava K, Hensel A, Szostak M, Resch S, Lubitz W: Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 2002,85(1-3):17-25. 10.1016/S0168-3659(02)00267-5CrossRefPubMed
4.
go back to reference Eko FO, Witte A, Huter V, Kuen B, Fürst-Ladani S, Haslberger A, Katinger A, Hensel A, Szostak MP, Resch S, et al.: New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine 1999,17(13-14):1643-1649. 10.1016/S0264-410X(98)00423-XCrossRefPubMed Eko FO, Witte A, Huter V, Kuen B, Fürst-Ladani S, Haslberger A, Katinger A, Hensel A, Szostak MP, Resch S, et al.: New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine 1999,17(13-14):1643-1649. 10.1016/S0264-410X(98)00423-XCrossRefPubMed
5.
go back to reference Kudela P, Paukner S, Mayr UB, Cholujova D, Schwarczova Z, Sedlak J, Bizik J, Lubitz W: Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother 2005,28(2):136-143. 10.1097/01.cji.0000154246.89630.6fCrossRefPubMed Kudela P, Paukner S, Mayr UB, Cholujova D, Schwarczova Z, Sedlak J, Bizik J, Lubitz W: Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother 2005,28(2):136-143. 10.1097/01.cji.0000154246.89630.6fCrossRefPubMed
6.
go back to reference Chang YH, Liu SG, Wang CL, Liu HF, Si W: Preparation of Actinobacillus pleuropneumoniae Ghosts. Chin J Pre Vet Med 2008, 30: 674-677. (In Chinese) Chang YH, Liu SG, Wang CL, Liu HF, Si W: Preparation of Actinobacillus pleuropneumoniae Ghosts. Chin J Pre Vet Med 2008, 30: 674-677. (In Chinese)
7.
go back to reference Witte A, Wanner G, Blasi U, Halfmann G, Szostak M, Lubitz W: Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E. J Bacteriol 1990,172(7):4109-4114.PubMedCentralPubMed Witte A, Wanner G, Blasi U, Halfmann G, Szostak M, Lubitz W: Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E. J Bacteriol 1990,172(7):4109-4114.PubMedCentralPubMed
8.
go back to reference Evans GA, Margulies DH, Shykind B, Seidman JG, Ozato K: Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature 1982,300(5894):755-757. 10.1038/300755a0CrossRefPubMed Evans GA, Margulies DH, Shykind B, Seidman JG, Ozato K: Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature 1982,300(5894):755-757. 10.1038/300755a0CrossRefPubMed
9.
go back to reference Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, Ignatyev G: Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 2005,73(8):4810-4817. 10.1128/IAI.73.8.4810-4817.2005PubMedCentralCrossRefPubMed Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, Ignatyev G: Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 2005,73(8):4810-4817. 10.1128/IAI.73.8.4810-4817.2005PubMedCentralCrossRefPubMed
10.
go back to reference Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W: Bacterial ghosts: non-living candidate vaccines. J Biotechnol 1996,44(1-3):161-170. 10.1016/0168-1656(95)00123-9CrossRefPubMed Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W: Bacterial ghosts: non-living candidate vaccines. J Biotechnol 1996,44(1-3):161-170. 10.1016/0168-1656(95)00123-9CrossRefPubMed
11.
go back to reference Zhang RP, Zhang ZS: Advances on the novel drug deliver system: bacterial ghost. Prog Bioche Biophys 2006, 33: 622-626. Zhang RP, Zhang ZS: Advances on the novel drug deliver system: bacterial ghost. Prog Bioche Biophys 2006, 33: 622-626.
12.
go back to reference Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU: Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 2003,21(15):1694-1703. 10.1016/S0264-410X(02)00677-1CrossRefPubMed Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU: Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 2003,21(15):1694-1703. 10.1016/S0264-410X(02)00677-1CrossRefPubMed
13.
go back to reference Jechlinger W, Haller C, Resch S, Hofmann A, Szostak MP, Lubitz W: Comparative immunogenicity of the Hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine 2005,23(27):3609-3617. 10.1016/j.vaccine.2004.11.078CrossRefPubMed Jechlinger W, Haller C, Resch S, Hofmann A, Szostak MP, Lubitz W: Comparative immunogenicity of the Hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine 2005,23(27):3609-3617. 10.1016/j.vaccine.2004.11.078CrossRefPubMed
14.
go back to reference Panthel K, Jechlinger W, Matis A, Rohde M, Szostak M, Lubitz W, Haas R: Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun 2003,71(1):109-116. 10.1128/IAI.71.1.109-116.2003PubMedCentralCrossRefPubMed Panthel K, Jechlinger W, Matis A, Rohde M, Szostak M, Lubitz W, Haas R: Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun 2003,71(1):109-116. 10.1128/IAI.71.1.109-116.2003PubMedCentralCrossRefPubMed
15.
go back to reference Hensel A, Huter V, Katinger A, Raza P, Strnistschie C, Roesler U, Brand E, Lubitz W: Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 2000,18(26):2945-2955. 10.1016/S0264-410X(00)00107-9CrossRefPubMed Hensel A, Huter V, Katinger A, Raza P, Strnistschie C, Roesler U, Brand E, Lubitz W: Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 2000,18(26):2945-2955. 10.1016/S0264-410X(00)00107-9CrossRefPubMed
16.
go back to reference Marchart J, Dropmann G, Lechleitner S, Schlapp T, Wanner G, Szostak MP, Lubitz W: Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates. Vaccine 2003,21(25-26):3988-3997. 10.1016/S0264-410X(03)00383-9CrossRefPubMed Marchart J, Dropmann G, Lechleitner S, Schlapp T, Wanner G, Szostak MP, Lubitz W: Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates. Vaccine 2003,21(25-26):3988-3997. 10.1016/S0264-410X(03)00383-9CrossRefPubMed
17.
go back to reference Wang N, Zeng WK, Guo G, Zou QM: Preparation and characterization of E. coli "bacterial ghost". Med J Chin PLA 2005, 30: 226-228. Wang N, Zeng WK, Guo G, Zou QM: Preparation and characterization of E. coli "bacterial ghost". Med J Chin PLA 2005, 30: 226-228.
18.
go back to reference Bläsi U, Lubitz W: Influence of C-terminal modifications of phi X174 lysis gene E on its lysis-inducing properties. J Gen Virol 1985,66(Pt 6):1209-1213.CrossRefPubMed Bläsi U, Lubitz W: Influence of C-terminal modifications of phi X174 lysis gene E on its lysis-inducing properties. J Gen Virol 1985,66(Pt 6):1209-1213.CrossRefPubMed
20.
go back to reference Buckley KJ, Hayashi M: Lytic activity localized to membrane-spanning region of phi X174 E protein. Mol Gen Genet 1986,204(1):120-125. 10.1007/BF00330198CrossRefPubMed Buckley KJ, Hayashi M: Lytic activity localized to membrane-spanning region of phi X174 E protein. Mol Gen Genet 1986,204(1):120-125. 10.1007/BF00330198CrossRefPubMed
21.
go back to reference Schüller A, Harkness RE, Ruther U, Lubitz W: Deletion of C-termlnal amino acid codons of PhiX174 gene E: effect on its lysis inducing properties. Nucleic Acids Res 1985,13(11):4143-4153. 10.1093/nar/13.11.4143PubMedCentralCrossRefPubMed Schüller A, Harkness RE, Ruther U, Lubitz W: Deletion of C-termlnal amino acid codons of PhiX174 gene E: effect on its lysis inducing properties. Nucleic Acids Res 1985,13(11):4143-4153. 10.1093/nar/13.11.4143PubMedCentralCrossRefPubMed
22.
go back to reference Henrich B, Lubitz W, Plapp R: Lysis of Escherichia coli by induction of cloned phi X174 genes. Mol Gen Genet 1982,185(3):493-497. 10.1007/BF00334146CrossRefPubMed Henrich B, Lubitz W, Plapp R: Lysis of Escherichia coli by induction of cloned phi X174 genes. Mol Gen Genet 1982,185(3):493-497. 10.1007/BF00334146CrossRefPubMed
23.
go back to reference Lin CS, Chen WT, Wong TT: High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II. Mol Microbiol 1992, 6: 3385-3393. 10.1111/j.1365-2958.1992.tb02206.xCrossRef Lin CS, Chen WT, Wong TT: High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II. Mol Microbiol 1992, 6: 3385-3393. 10.1111/j.1365-2958.1992.tb02206.xCrossRef
Metadata
Title
Enhancement of bacteriolysis of Shuffled phage PhiX174 gene E
Authors
Shen-ye Yu
Wei Peng
Wei Si
Lu Yin
Si-guo Liu
Hui-fang Liu
Hai-ling Zhao
Chun-lai Wang
Yue-hong Chang
Yue-zhi Lin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-206

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.